NEYROPSIXOLOGIK VA NEYROSENSOR BUZILISHLARDA "KRETAMIN" DORI VOSITASINING SAMARADORLIGINI TAHLIL QILISH
Keywords:
Kretamin, neyropsixologik buzilish, neyrosensor buzilish, GABA, Ginkgo biloba, serotonin, uyqu, eshitish, bosh aylanishi, depressiya.Abstract
Ushbu maqolada "Kretamin" dori vositasining neyropsixologik va neyrosensor buzilishlarga qarshi samaradorligi o‘rganilgan. Klinik tadqiqot doirasida 80 nafar bemorda preparatning kognitiv, emotsional va sezgi tizimlariga ijobiy ta’siri aniqlangan. Tadqiqot natijalari asosida "Kretamin"ning kompleks neyroprotektor va metabolik faolligi asoslangan.
References
1.
2.
3.
4.
5.
6.
7.
8.
9.
World Health Organization. Mental health action plan 2013–2020. Geneva:
WHO, 2013.
Patel V. et al. Addressing the burden of mental, neurological, and substance use
disorders: key messages from Disease Control Priorities. The Lancet, 2016;
387(10028): 1672–1685.
Gusev E.I., Skvortsova V.I. Neyrologiya. Moskva: GEOTAR-Media, 2021.
Yakovlev V.N. Neyropsixologicheskie sindromy i ikh terapiya. Sankt
Peterburg: ELBI-SPb, 2020.
Gerasimova M.E. Modern pharmacological approaches to the correction of
cognitive impairments. Bulletin of Experimental Biology and Medicine, 2019;
168(9): 102–106.
Lishman W.A. Organic Psychiatry: The Psychological Consequences of
Cerebral Disorder. Oxford: Wiley-Blackwell, 2017.
Yuldashev U.U. et al. The role of adaptogenic therapy in the management of
stress-related autonomic dysfunctions. Uzbek Medical Journal, 2020; 6: 45–48.
Zohidov K.K. Neyroendokrin regulyatsiya va psixovegetativ sindromlar.
Toshkent: TMA, 2021.
Kilichev S.A., Abdurakhmonov I.R. Clinical and immunometabolic efficacy of
“Kretamin” in patients with neurodegenerative syndromes. Neurology and
Psychiatry, 2023; 2(5): 38–44.
10. Azizova G.A. Antioxidant protection in neurodegeneration: pharmacological
correction strategies. Modern Problems of Science and Education, 2021; 1: 56
59.
11. Cummings J.L., Mega M.S. Neuropsychiatry and Behavioral Neuroscience.
Oxford University Press, 2018.
12. Abdurakhimova N.K. Application of metabolically active preparations in
complex treatment of cerebral atherosclerosis. Clinical Pharmacology Journal,
2022; 3: 19–23.13. Jumaeva N.S. Use of combined adaptogenic complexes in psychosomatic
dysfunctions. Medical Science and Innovation, 2023; 7(4): 71–74.
14. Karimov B.R. Kretaminning miya qon aylanishi buzilishlarida qo‘llanishi.
Tibbiyotda innovatsiyalar, 2024; 2: 27–32.
15. Bechtereva N.P. Mozg i psixika: neyrofiziologicheskie issledovaniya. Sankt
Peterburg: Nauka, 2019.
16. Khoshimov R.S. Asab kasalliklari klinikasi va farmakoterapiyasi. Toshkent:
Tibbiyot, 2022.
17. WHO. Depression and Other Common Mental Disorders. Global Health
Estimates. Geneva, 2017.
18. Azizova M.M. Antistress effects of metabolic agents in experimental neurosis.
Central Asian Medical Journal, 2022; 5: 82–85.
19. Sarimsoqov M.A. Bioregulyatorlar va ularning psixotrop ta’siri. Toshkent:
FAN, 2023.
